Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-containing regimen for multidrug-resistant HIV-1 infection
ChiCTR2400081019Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Yuexi County
- Start
- Feb 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of albuvirtide in Human immunodeficiency virus infection type 1 and acquired immunodeficiency syndrome (AIDS), sponsored by The First People's Hospital of Yuexi County. Primary endpoint: HIV-1 RNA. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
albuvirtide
03
Conditions
Human immunodeficiency virus infection type 1acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on ChiCTR2400081019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081019.